LAUREATE EDUCATION, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LAUREATE EDUCATION, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.48B | Feb 22, 2024 |
| FY2023 | Dec 31, 2022 | $1.24B | Feb 22, 2024 |
| FY2023 | Dec 31, 2021 | $1.09B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $285.22M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $243.52M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $303.86M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $192.32M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $351.85M | Feb 25, 2021 |
| FY2020 | Sep 30, 2019 | $277.27M | Feb 25, 2021 |
| FY2020 | Jun 30, 2019 | $370.94M | Feb 25, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.70B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.57B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.48B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.24B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.09B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.02B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.21B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.14B | Feb 25, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $281.63M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $296.47M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $107.59M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $69.57M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $192.45M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $379.32M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | ($784.44M) | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | ($307.82M) | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $99.62M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $60.88M | Feb 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $431.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $373.98M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $338.82M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $270.01M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | ($4.65M) | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $36.88M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | ($318.24M) | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $29.14M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | ($77.09M) | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $57.32M | Feb 25, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $366.19M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $232.73M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $250.78M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $178.23M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | ($156.08M) | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $259.56M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $339.77M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $396.86M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $192.16M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $192.26M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.21B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.86B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $2.13B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.97B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.21B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $4.97B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $6.50B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $6.77B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $7.39B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $7.06B | Mar 20, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.02B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $903.52M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $1.18B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.20B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.07B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.71B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $3.68B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $4.70B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $5.39B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $6.04B | Mar 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.19B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $959.55M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $950.07M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $776.23M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.14B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.28B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.82B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.06B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.58B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $632.21M | Mar 20, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $637.30M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $563.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $661.48M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $583.49M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $546.80M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $574.83M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $606.48M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $578.52M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.83B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.79B | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $416.89M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $291.64M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $41.86M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $39.24M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $15.52M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($176.82M) | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $436.51M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | ($530.92M) | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | ($946.24M) | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | ($1.04B) | Mar 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $146.70M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $91.35M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $89.39M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $85.17M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $324.80M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $750.15M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $61.58M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $77.77M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $319.04M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $295.79M | Feb 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 3 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 3 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 142.94M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 150.79M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 157.59M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | 157.01M | Feb 22, 2024 |
| FY2021 | Dec 31, 2021 | 180.61M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Feb 24, 2022 |
| FY2018 | Dec 31, 2018 | 0 | Feb 28, 2019 |
| FY2018 | Dec 31, 2017 | 133.38M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 133.38M | Mar 20, 2018 |